Sector consensus Attovia Therapeutics, Inc.
Stocks
ATTO
US04987L1026
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 16.31 USD | -0.67% |
|
-8.32% | - |
| 09-20 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | 42.2 | +157% | 5 | |||
| 190.75 | +13.99% | 17 | ||||||
| 1,169.71 | +24.63% | 15 | ||||||
| 688.17 | +19.23% | 23 | ||||||
| 258.84 | +28.86% | 23 | ||||||
| 292.16 | +13.19% | 19 | ||||||
| 435.2 | +19.55% | 27 | ||||||
| 267,741.48 | +45.91% | 22 | ||||||
| 103.36 | +22.24% | 20 | ||||||
| 197.74 | +94.36% | 23 | ||||||
| 2,537.12 | +2.02% | 15 | ||||||
| 591.85 | -2.05% | 13 | ||||||
| 1,482.61 | +23.04% | 8 | ||||||
| 72.29 | -5.52% | 14 | ||||||
| 273.03 | +34.53% | 20 | ||||||
| 310.53 | +3.41% | 15 | ||||||
| 54.53 | -6.68% | 15 | ||||||
| 22.51 | +65.77% | 13 | ||||||
| 70.61 | +0.37% | 18 | ||||||
| 184.41 | +12.39% | 17 | ||||||
| Average | 13,835.96 | +28.31% | 17 | ||||||
| Weighted average by Cap. | 16,010.56 | +22.37% | 19 |
- Stock Market
- Stocks
- ATTO Stock
- Sector Attovia Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
